Agendia, Inc.: Agendia Studies Reveal the Influence of Race on a Tumor's Biology, Reinforcing its Commitment to Advancing Research of Racial Disparities in Breast Cancer
Data presented at the 2023 ASCO® Annual Meeting confirms BluePrint® accurately reveals the driving forces behind a tumor's growth, independent of race With over 1,000 Black women enrolled